I bought in a few days ago. Given their cash, relationships with some big pharmas and all if the trials going on, they should be worth more than 300 million
Nice to have you aboard :-). I jumped on, on the 24th but have added since including today. I'm generally not into competitive areas but I think Dew laid out a nice bull case and I agree that AbbVie ..stands to get a substantial market share.